Legend Biotech (LEGN) Debt to Equity (2021 - 2025)
Legend Biotech (LEGN) reported Debt to Equity of $0.32 for Q4 2025, up 10.01% on a YoY basis from $0.29 in Q4 2024, and up 125.39% quarter-over-quarter from $0.14 in Q3 2025.
Legend Biotech (LEGN) Debt to Equity (2021 - 2025) Analysis & Trends
Legend Biotech has reported Debt to Equity for 5 years, with the latest figure at $0.32 in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity rose 10.01% year-over-year to $0.32; the trailing twelve-month figure through Dec 2025 stood at $0.32 (up 10.01% YoY), and the FY2025 full-year result was $0.32, up 10.01% from the prior year.
- Debt to Equity for Q4 2025 stood at $0.32, up from $0.14 in the prior quarter.
- The five-year high for Debt to Equity was $0.41 in Q1 2023, with the low at $0.0 in Q2 2021.
- Historically, Debt to Equity has averaged $0.24 across 5 years, with a median of $0.25 in 2024.
- Annual changes were most pronounced in 2023 — Debt to Equity soared 138.08% — and 2025, when it tumbled 46.84%.
- Legend Biotech's Debt to Equity stood at $0.16 in 2021, then jumped by 122.9% to $0.35 in 2022, then tumbled by 35.87% to $0.22 in 2023, then advanced by 28.75% to $0.29 in 2024, then advanced by 10.01% to $0.32 in 2025.
- The last three Debt to Equity figures came in at $0.32 (Q4 2025), $0.14 (Q3 2025), and $0.3 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.32 |
| Sep 30, 2025 | 0.14 |
| Jun 30, 2025 | 0.30 |
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 0.29 |
| Sep 30, 2024 | 0.27 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.19 |
| Mar 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.35 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.16 |
| Sep 30, 2021 | 0.31 |
| Jun 30, 2021 | 0.00 |